About Shield Therapeutics

What does Shield Therapeutics do?

Shield Therapeutics is a provider of late-stage, mineral-derived hospital pharmaceuticals addressing areas of high unmet medical need, focused on development and commercialization. Offers ACCRUFER, an oral therapy for adults with iron deficiency with or without anemia, and drug safety services monitoring and addressing the safety of patients using its products.

Who are Shield Therapeutics's competitors?

Shield Therapeutics's competitors and similar companies include Proacta, CellaVision, Tasso, Medcura, and Hemcheck.

Where is Shield Therapeutics headquartered?

Shield Therapeutics is headquartered in United Kingdom.

How many employees does Shield Therapeutics have?

Shield Therapeutics has 1,000 employees 🔒.

When was Shield Therapeutics founded?

Shield Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Shield Therapeutics in?

Shield Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Shield Therapeutics

Who are the top strategic acquirers in Shield Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Shield Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Shield Therapeutics?

Top strategic M&A buyers groups and sectors for Shield Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Shield Therapeutics's sector and industry vertical

Which are the top PE firms investing in Shield Therapeutics's sector and industry vertical?

Top PE firms investing in Shield Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Shield Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Shield Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Shield Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Shield Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Shield Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Shield Therapeutics?

The key public trading comparables and valuation benchmarks for Shield Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Shield Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Shield Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Shield Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Shield Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Shield Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Shield Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.